Comparison of the QuantiFERON-TB® Gold Plus on LIAISON® XL and T-SPOT.TB for the diagnosis of latent Mycobacterium tuberculosis infection in a low tuberculosis incidence population
- 1 March 2022
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 102 (3) , 115613
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Comparison of QuantiFERON-TB Gold Plus, QuantiFERON-TB Gold In-Tube, and T-SPOT.TB among patients with tuberculosisJournal of Infection and Chemotherapy, 2020
- QuantiFERON-TB Gold Plus: High Qualitative and Quantitative Agreement between Enzyme-Linked Immunosorbent Assay (ELISA) and Chemiluminescence Immunoassay (CLIA)Journal of Clinical Microbiology, 2020
- Sensitivity and specificity of QuantiFERON-TB Gold Plus compared with QuantiFERON-TB Gold In-Tube and T-SPOT.TB on active tuberculosis in JapanJournal of Infection and Chemotherapy, 2018
- Lymphocyte subset analysis in QuantiFERON-TB Gold Plus and T-Spot.TB for latent tuberculosis infection in rheumatoid arthritisJournal of Infection and Chemotherapy, 2018
- Interferon Gamma Release Assays for Latent Tuberculosis: What Are the Sources of Variability?Journal of Clinical Microbiology, 2016
- Interferon-gamma release assays for tuberculosis: current and future applicationsExpert Review of Respiratory Medicine, 2013
- Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the EvidencePulmonary Medicine, 2013
- Interferon-γ release assays for the diagnosis of latentMycobacterium tuberculosisinfection: a systematic review and meta-analysisEuropean Respiratory Journal, 2010
- Interferon-Gamma Release Assay for the Diagnosis of Latent TB Infection – Analysis of Discordant Results, when Compared to the Tuberculin Skin TestPLOS ONE, 2008